Showing 471-480 of 3326 results for "".
The Future of Interleukin-based Therapy
https://practicaldermatology.com/topics/practice-management/the-future-of-interleukin-based-therapy/21133/IL inhibitors offer the promise of increased efficacy. Here is a snapshot view of current and investigational agents.Herbals in the Holistic Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/herbals-in-the-holistic-treatment-of-psoriasis/21055/Dermatologists must be aware of the herbal supplements patients may take and their potential effects.Updates on Nitric Oxide As a Topical Anti-infective
https://practicaldermatology.com/topics/practice-management/updates-on-nitric-oxide-as-a-topical-anti-infective/21071/NO continues to show promise as a safe and effective topical treatment candidate for acne and other infectious dermatoses.Warfarin-Induced Nonuremic Calciphylaxis: A Case Study and Overview
https://practicaldermatology.com/youngmd-connect/resident-resource-center/warfarin-induced-nonuremic-calciphylaxis-a-case-study-and-overview/23872/Planning Ahead: Saving for the High Cost of College
https://practicaldermatology.com/topics/practice-management/planning-ahead-saving-for-the-high-cost-of-college/23210/Should you use a 529 plan?Are You Paying Too Much In Taxes?
https://practicaldermatology.com/topics/practice-management/are-you-paying-too-much-in-taxes/23054/How a common tax mistake can cost you thousands.Take 5: Strategies for Optimal Outcomes with Dermal Fillers
https://practicaldermatology.com/columns/take-5/take-5-strategies-for-optimal-outcomes-with-dermal-fillers/21949/A dermatologic surgeon's tips for getting the most from dermal fillers and improving patient satisfaction.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Revisiting Cyclosporine in the Age of Biologics: Update on Efficacy and Mechanism of Action
https://practicaldermatology.com/topics/general-topics/revisiting-cyclosporine-in-the-age-of-biologics-update-on-efficacy-and-mechanism-of-action/21937/Increased understanding of the immunologic basis of psoriasis supports the role of cyclosporine in patient management.Verrucous Psoriasis
https://practicaldermatology.com/topics/psoriasis/verrucous-psoriasis/27148/Verrucous psoriasis (VP) is a rare subtype of psoriasis most commonly affecting middle-aged to older adults, with fewer than 35 reported cases within the current literature. It is characterized by symmetric wart-like, hyperkeratotic, papillomatous plaques. Treatment options are limited and variable,